2012 NHIA Annual Conference & Exposition

2012 NHIA Executive Pre-Conference

The NHIA Executive Pre-Conference

Requires separate registration

Includes continental breakfast (that opens at 6:30 AM) and lunch.

Can fill up quickly and space is limited—early pre-registration is strongly encouraged!

Monday, April 23

Transcending Uncertainty to Best Position Your Alternate-Site Infusion Business for Success

Supported by the generous sponsorship of Managed Health Care Associates, Inc.

mha

7:00 AM - 1:00 PM
Sheraton Phoenix Downtown

Pharmacist, Pharmacy Technician and Nurse Continuing Education Contact Hours: 5

Education Overview:
 The NHIA Executive Pre-Conference is specifically designed for senior executives, owners, managers and other leaders in the field who are seeking bold, new ideas and strategies for maintaining a relevant and thriving alternate-site infusion business—all amid changing and economically challenging times. Hear from veteran, highly skilled industry leaders, as you investigate how best to transcend the uncertainty in health care today and position your business for future success:

  • State of the Industry—A Comprehensive Overview
    Health care reform legislation enacted in mid-2010 continues to provoke many questions among alternate-site infusion providers contemplating the eventual effect it will have on their businesses. Encompassing a number of untested economic approaches for health care delivery—including accountable care organizations (ACOs) and bundled payment methodologies that cross multiple sites of care in patient-centered delivery models—the full consequence of this sweeping legislation is still not clear. Adding to this uncertainty is the ongoing drug pricing dilemma and continually shrinking margins, as payers seek evermore cost-effective means of delivering patient care. With updates on a host of topics poised to impact home infusion companies in the coming year, attendees will find this presentation invaluable to their strategic planning processes as they work to transcend the many areas of uncertainty confronting the industry—and their own organizations.
  • The Pharmaceutical Pipeline—Considerations for Alternate-Site Infusion
    In a health care field built upon the administration of infused or injected drugs, the pharmaceutical pipeline holds significant interest and power in determining the future. From a sustained focus on specialty pharmacy drug development, to an explosion of new generic drugs in the next five years, providers will glean critical information about the medications upon which their business relies—and the key steps they can take now to prepare for emerging changes and opportunities. Explore the new molecular entities presently under development, focusing on those poised to have the greatest impact on alternate-site infusion. From blockbuster medications to oral agents that may replace traditional infused therapies, change is imminent—and providers who have this vital knowledge will be in the best position to plan accordingly, respond and thrive.
  • Mergers & Acquisitions—The View from the Buyer's Perspective
    The alternate-site infusion industry is no stranger to periods of intense merger and acquisition activity, driven by a variety of field-related and economic forces. Furthermore, a new development in recent years is the growth of venture capital investment into our market, creating a number of large, regional infusion pharmacies. Private equity firm investment is just one of several trends that will be discussed in this engaging session that examines mergers and acquisitions (M&A) from the buyer's perspective. Receive an insider's view of the specific parameters that are the hallmarks of an "acquisition-worthy" alternate-site infusion pharmacy, from organizational culture to reputation for quality care. Whether you are contemplating selling your business or striving to compete in a market that is ripe for M&A—or even looking to make acquisitions—all providers will gain indispensable insights about the dynamics of our evolving marketplace, as well as the current and future face of competition in our health care sector.
  • CEOs Unplugged—Business Leaders Sharing Their Thoughts About Our Field's Current Events and Future Opportunities
    As demonstrated in NHIA's recently published Phase I: 2010 NHIA Provider Survey, Comprehensive Aggregate Analysis Report, alternate-site infusion companies share many common characteristics at the individual licensed pharmacy level, despite the wide-range of infusion provider "types" that exist in our industry. Leveraging both our commonalities and diversity as a field, a representative panel of industry executives will share their perspectives on some of the most significant challenges and opportunities we are encountering in these uncertain times of evolving health care reform and reimbursement compression. Via a candid panel-discussion format, you will hear several successful leaders in our field offer their views on the foundational aspects of a flourishing home infusion business—from strategic planning to industry-wide data collection, as well as the application of technology to advance your corporate mission and bottom line.

Faculty: Thomas D. Brown, RPh, MBA, Director, Jefferson Home Infusion Service, Philadelphia, PA; Jim Glynn, President & CEO, Amerita Specialty Infusion Services, Irvine, CA; Dan Greenleaf, MBA, CEO, Coram Specialty Infusion Services, Denver, CO; Paul Mastrapa, MBA, President, Walgreens Infusion and Respiratory Services, Buffalo Grove, IL; Stacey Ness, PharmD, RPH, MSCS, Director of Specialty Clinical Services, Managed Health Care Associates, Florham Park, NJ; Michael J. Sicilian, President, Managed Health Care Associates, Inc., Florham Park, NJ; Rick Smith, CEO, Bioscrip, Elmsford, NY; Dana W. Soper, RPh, MBA, CEO, CarePoint Partners, Cincinnati, OH; Sandy Tzaferos, PharmD, President, MediLink Home Care, Inc., Hammonton, NJ; Christopher J. York, CEO, SCP Specialty Infusion, Chicago, IL